The effect of hypolipidemic treatment on monocyte cytokine release in different age groups of patients with type 2 diabetes and atherogenic dyslipidemia.
CONCLUSIONS: Our results suggest that age may partially determine monocyte-suppressing and systemic anti-inflammatory effects of fenofibrate.
PMID: 26884290 [PubMed - as supplied by publisher]
Source: Endokrynologia Polska - Category: Endocrinology Authors: Krysiak R, Gdula-Dymek A, Marek B, Okopień B Tags: Endokrynol Pol Source Type: research
More News: Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Fenofibrate | Fortamet | Insulin | Metformin | Simvastatin | Statin Therapy | Study | Tricor | Zocor